Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_assertion type Assertion NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_head.
- NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_assertion description "[The aim of this study was to evaluate whether the neoadjuvant use of the dexamethasone (DEX) plus octreotide (OCT) regimen can improve the direct anticancer effects of docetaxel (DOC) in the TRAMP-C1 prostate cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_provenance.
- NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_assertion evidence source_evidence_literature NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_provenance.
- NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_assertion SIO_000772 22210719 NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_provenance.
- NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_assertion wasDerivedFrom befree-20150227 NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_provenance.
- NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_assertion wasGeneratedBy ECO_0000203 NP873553.RARYg9OGoze7Zh7iotKIkt9rWo9VXImynSIfOSdcof4LY130_provenance.